Wockhardt Exits Sepracor's Lunesta Patent Suit
The settlement, approved Thursday in the U.S. District Court for the District of New Jersey, enjoins Wockhardt from manufacturing generic Lunesta until one of the patents-in-suit expires in November 2013 or May 2014, depending on potential extensions. That date could move forward if the parties reach a licensing agreement, according to the stipulation.
"This reasonable final settlement will...
To view the full article, register now.